Vor Biopharma Inc. ( VOR) - Stock Earnings
VOR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 11, 2026, midnight | — / — | — | — / — | — |
VOR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 1.7 billion USD | — USD |
| 2026Q1 | -219.6 million USD | — USD |
| 2026Q2 | -62.8 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
VOR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -117.9 million USD | — USD |
| 2024 | -116.9 million USD | — USD |
| 2025 | -696.0 million USD | — USD |
| 2026 Est. | — | — |
VOR
Price: $23.01
Earnings Per Share: 171.01 USD
P/E Ratio: 0.13
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 63919
Market Capitalization: 1.2 billion